Corbus Pharma (CRBP) Misses Q2 EPS by 55c
Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($1.81), $0.55 worse than the analyst estimate of ($1.26).
For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.
Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($1.81), $0.55 worse than the analyst estimate of ($1.26).
For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.